Filter
982
Filtered Results: 982
Text search:
World
Health
Organization,
Western
Pacific
Office
Featured
Recommendations
111
New Publications
240
Language
Document type
No document type
465
Studies & Reports
228
Guidelines
154
Manuals
54
Strategic & Response Plan
42
Training Material
13
Situation Updates
9
Fact sheets
7
Resource Platforms
6
Infographics
3
Online Courses
1
Countries / Regions
Global
84
Philippines
40
Western Pacific Region
24
South–East Asia Region
21
Asia
18
Nepal
17
India
16
Cambodia
15
Western and Central Europe
15
Myanmar / Burma
15
Africa
12
Bangladesh
11
Kenya
9
Latin America and the Carribbean
9
Liberia
8
Sierra Leone
7
China
7
Russia
7
Syria
6
Indonesia
6
Thailand
5
Nigeria
5
Afghanistan
5
Eastern Europe and Central Asia
5
Papua New Guinea
5
Ethiopia
5
Pakistan
5
Ukraine
4
Rwanda
4
Middle East and North Africa
4
South Africa
4
Eastern Europe
4
Ghana
3
Mozambique
3
Congo, Democratic Republic of
3
Vietnam
3
Yemen
3
South Sudan
3
Somalia
3
Madagascar
3
Laos
2
Malawi
2
Zimbabwe
2
Mongolia
2
Guinea
2
USA
2
Venezuela
2
West and Central Africa
2
East and Southern Africa
2
Sri Lanka
2
North Korea
1
Timor Leste/ East Timor
1
Mexico
1
Benin
1
Iran
1
Fiji
1
Burkina Faso
1
Peru
1
Vanuatu
1
Haiti
1
Tanzania
1
Jordan
1
Japan
1
Moldova
1
Sudan
1
Palestine
1
Central African Republic
1
Bhutan
1
Zambia
1
Iraq
1
Ecuador
1
Solomon Islands
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
176
Clinical Guidelines
121
Key Resources
77
Public Health
73
Women & Child Health
61
Pharmacy & Technologies
21
Capacity Building
16
Toolboxes
Mental Health
95
HIV
93
COVID-19
80
Planetary Health
62
Rapid Response
60
TB
51
Global Health Education
38
NTDs
36
Disability
33
AMR
31
Caregiver
27
Pharmacy
26
NCDs
21
Natural Hazards
19
Zika
19
Conflict
17
Refugee
16
Health Financing Toolbox
14
Ebola & Marburg
10
Polio
7
Specific Hazards
4
Typhoon
4
Cholera
3
Malaria
3
Social Ethics
1
Interim Guidance
23 décembre 2020 Ce document résume les recommandations de l'OMS concernant l'utilisation rationnelle des équipements de protection individuelle (EPI) dans les établissements de soins de santé et les stratégies temporaires en cas de pénurie aiguë d'approvisionnement. Ce document contient ég...
These guidelines provide specific recommendations and expert suggestions — for national policy-makers and programme managers and their partners and stakeholders— on prioritizing, planning and providing HIV testing, counselling, treatment and care services for adolescents
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets trends in biosafety.
LBM encouraged countries t...
En la actualidad, los daños que sufren los pacientes a causa de una atención poco segura constituyen un desafío
importante y creciente para la salud pública mundial y son una de las principales causas de muerte y discapacidad
en todo el mundo. La mayor parte de estos daños son evitables. Ahor...
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve...
WHO published the first COVID-19 Strategic Response and Preparedness Plan (SPRP) on 3 February, 2020. This report highlights the main points of progress that were made up to 30 June 2020 under the three objectives outlined in the SPRP: scaling up international coordination and support; scaling up co...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
Um Manual Passo A Passo
The mhGAP community toolkit: field test version is an integral part of WHO's Mental Health Gap Action Programme (mhGAP), and aims at scaling up services for people with mental health conditions to achieve universal health coverage.
The toolkit provides guidance for programme managers on how to i...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei...
Setting WHO directions
The report is geared towards mayors, local government officials and city policy planners.It highlights key areas where city leaders can tackle the drivers of NCDs, including tobacco use, air pollution, poor diets and lack of exercise, and improve road safety.
From anti-tobacco actions in Beijing a...
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
The primary audience for this guidance is persons
working directly in vector-borne disease prevention
and control, including programme managers,
researchers and field workers. A brief technical
background is provided for the benefit of persons
without expertise in vector-borne diseases; readers...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
